The Preeclampsia Foundation is pleased to announce the establishment of the Peter Joseph Pappas Fund, a restricted fund with the primary goal of supporting research that will end pre-term deliveries due to preeclampsia and related disorders of pregnancy by 2050.
Established by Clement and Lauren Pappas of Philadelphia, PA, in honor of their son, Peter Joseph, the fund will help support new and innovative approaches to researching this age-old disease that still has no cure. Peter Joseph died after being born prematurely due to severe HELLP syndrome experienced by Lauren at 28 weeks.
Clement and Lauren have set their goal for $1 million in donations from family and friends over the next five years. Generous donations to date have already surpassed $135,000 and pledges have reached $835,000.
The Preeclampsia Foundation's mission is to reduce maternal and infant illness and death due to preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy. As the only nonprofit in the U.S. dedicated to these diseases, the Preeclampsia Foundation is dedicated to keeping families whole.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Hypertensive disorders of pregnancy significantly increase your risk of developing long-term heart problems. A careful review of blood pressure elevations during and after pregnancy may assist in iden...
Hypertensive disorders of pregnancy (HDP) can affect different groups of women in different ways, and even though we know this happening, we don't fully understand why. There are many factors, like bi...
There is growing evidence that studies examining pregnancy and its complications need to start early within the pregnancy to fully understand the nature of preeclampsia. Key gestational milestones, wh...
It is known that chronic hypertension and high BMI (body mass index) are risk factors for hypertensive disorders of pregnancy (HDP). Studies documenting this risk have usually assessed blood pre...
Several biomarker tests are under development to predict or diagnose preeclampsia. While none of these tests are yet widely accepted in U.S. clinical practice, two FDA-approved tests are available in...
